Articles by 윤정현
윤정현
-
Nam Hwa Construction wins W15b construction deal
[DISCLOSURE] Nam Hwa Construction (091590) announced on Sept. 9 that it has signed a 15.2 billion won (US$13.81 million) contract to build an apartment complex in Gwangju.The deal amounts to 30.18 percent of its last year’s revenue and expires March 30, 2019. By Yun Jeong-hyeon (clareyun@heraldcorp.com)
Sept. 9, 2016
-
Korea, Laos sign 18 economic cooperation MOUs
[THE INVESTOR] South Korea and Laos signed 18 memoranda of understanding on Sept. 9 to deepen bilateral cooperation in trade, investment, health care, infrastructure development and cultural exchanges, Cheong Wa Dae said.The MOUs, mostly about economic cooperation, were inked after the summit between South Korean President Park Geun-hye and her Laotian counterpart Bounnhang Vorachith in Vientiane. Laos is the third and last leg of Park’s eight-day trip that also took her to Russia and China.Amon
Sept. 9, 2016
-
KCS signs W5b contract with KB Card
[DISCLOSURE] KCS (115500) announced on Sept. 9 that it has signed a 5.3 billion won (US$ 4.81 million) contract with KB Kookmin Card to provide a credit card approval system and sell all outdated equipment. This amounts to 26.62 percent of its revenue last year. The contract ends Dec. 8. By Yun Jeong-hyeon (clareyun@heraldcorp.com)
Sept. 9, 2016
-
Medytox to close stockholder registry
[DISCLOSURE] Biopharmaceutical company Medytox (086900) will close its stockholder registry from Oct. 1 to 7 to sort out those entitled to interim dividends, the company reported on Sept. 9. By Yun Jeong-hyeon (clareyun@heraldcorp.com)
Sept. 9, 2016
-
NH SPAC No. 3 to acquire Korea Cement
[DISCLOSURE] NH SPAC No. 3 (198440) announced on Sept. 8 that it will acquire unlisted firm Korea Cement to improve its credit standing and its ability to finance the operation while improving management transparency. The merger will be finalized on Feb. 7, 2017 and the ratio for the merger is 1: 2.17.By Yun Jeong-hyeon (clareyun@heraldcorp.com)
Sept. 9, 2016
-
Innowireless obtains patent for mobile handover testing system
[DISCLOSURE] Innowireless (073490) reported on Sept. 9 that it has obtained a patent for mobile device handover testing system. A mobile phone connected within the service area with multiple base stations has been tested moving to a different service area without any interruption of service. By Yun Jeong-hyeon (clareyun@heraldcorp.com)
Sept. 9, 2016
-
Jeil Pharmaceutical spins off Jeil Health Science
[DISCLOSURE] Jeil Pharmaceutical (002620) announced on Sept. 8 that it will spin off its non-prescription medicine business division.The new company, Jeil Health Science, will be devoted to developing new over-the-counter drugs. Jeil Pharmaceutical will remain a public company and continue managing prescription medicine brands. The due date is Nov. 11.By Yun Jeong-hyeon (clareyun@heraldcorp.com)
Sept. 8, 2016
-
Ugint signs W16m supply contract with Chinese firm
[DISCLOSURE] Ugint (195990), a machine tools manufacturing company, said on Sept. 8 that it has signed a 16.26 million won (US$14.88 million) contract with a machinery and equipment company in Shanghai to supply mobile phone processing and manufacturing equipment. This amounts to 21.10 percent of its consolidated revenue and expires Dec. 31. Its Weihai affiliate will be in charge of manufacturing and distribution, the company added. By Yun Jeong-hyeon (clareyun@heraldcorp.com)
Sept. 8, 2016
-
TELCON to raise capital by W35b
[DISCLOSURE] TELCON (200230) has decided on a 35.02 billion won (US$32 million) capital increase by share allocation to its stockholders, the company announced on Sept. 8. They will be issued at a price of 7,800 won per share. By Yun Jeong-hyeon (clareyun@heraldcorp.com)
Sept. 8, 2016
-
Access Bio receives W2b research support from Gates Foundation
[DISCLOSURE] Access Bio (950130) -- which specializes in research, development and manufacturing of in vitro rapid diagnostic tests, biosensor and molecular diagnostic products -- has received 2 billion won (US$ 1.82 million) from the Bill & Melinda Gates Foundation.The foundation will provide funds until Feb. 1, 2018, to support its research and development to improve sensitivity of malaria diagnostic methods, the company added. By Yun Jeong-hyeon (clareyun@heraldcorp.com)
Sept. 8, 2016
-
SKC to hold IR session on Sept. 20
[DISCLOSURE] SKC (011790) which manufactures and distributes propylene oxide products said on Sept. 8 that it will hold an IR session for its investors with a presentation on future high-demand products such as CPI, TAC Alternative and PVB. The event will be held at Shinhan Investment Tower in Yeouido, central Seoul, on Sept. 20. By Yun Jeong-hyeon (clareyun@heraldcorp.com)
Sept. 8, 2016
-
Iran’s investment plan in Korean biotech city stalls
[THE INVESTOR] Iran’s plan to invest a total of US$2 billion in a major biotech complex in South Korea has stalled despite eased foreign currency transaction rules, industry observers said on Sept. 7.Earlier this year, a consortium led by the Iranian government signed a memorandum of understanding with the government of North Chungcheong Province.The Iranian side first agreed to provide $2 million for its initial investment into Osong Biovalley inside the province‘s free economic zone between Ju
Sept. 7, 2016
-
Health products overtake Korean beef as most popular Chuseok gifts
[THE INVESTOR] Vitamins and other health products have overtaken Korean beef as the most popular gifts for next week’s Chuseok holiday, data showed on Sept. 7.Health products accounted for 36.5 percent of gift set sales at Lotte Department Store from Aug. 26 to Sept. 5, according to data compiled by the major South Korean department store.Health products were followed by processed foods and daily necessities with 20.1 percent. Sales of Korean beef, known as hanwoo, came in a distant third with 9
Sept. 7, 2016
-
Korea to limit gov’t funds for int’l events
[THE INVESTOR] South Korea's government will limit state financing for costly international events hosted by provincial governments, the Finance Ministry here said on Sept. 7.In a government meeting on fiscal strategy chaired by Finance Minister Yoo Il-ho in Seoul, the government unveiled its decision to refrain from giving out unplanned money to local governments hosting international sports tournaments or exhibitions, according to the ministry.“Big international events have placed a large fina
Sept. 7, 2016
-
GNCO to finance Sumagen for AIDS vaccine
[DISCLOSURE] GNCO (065060) said on Sept. 7 that it will invest 3.62 billion won (US$3.31 million) in its subsidiary Sumagen by issuing 786,654 stocks to fund its clinical investigation for AIDS vaccine development. The amount is equivalent to 2.59 percent of the company’s equity capital.After the acquisition on Sept. 8, GNCO’s stake in the company will rise to 35.22 percent. By Yun Jeong-hyeon (clareyun@heraldcorp.com)
Sept. 7, 2016